Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients

MeSH terms

• Administration, Oral
• Arthralgia / chemically induced
• Benzoates / administration & dosage*
• Benzoates / adverse effects
• Benzoates / therapeutic use
• Chelation Therapy / methods*
• Deferasirox
• Deferiprone
• Deferoxamine / adverse effects
• Deferoxamine / therapeutic use
• Drug Administration Schedule
• Drug Eruptions / etiology
• Drug Therapy, Combination
• Female
• Humans
• Infusions, Subcutaneous
• Iron Chelating Agents / administration & dosage*
• Iron Chelating Agents / adverse effects
• Iron Chelating Agents / therapeutic use
• Iron Overload / drug therapy*
• Iron Overload / etiology
• Iron Overload / prevention & control
• Pyridones / administration & dosage*
• Pyridones / adverse effects
• Pyridones / therapeutic use
• Transfusion Reaction*
• Triazoles / administration & dosage*
• Triazoles / adverse effects
• Triazoles / therapeutic use
• Young Adult
• beta-Thalassemia / blood
• beta-Thalassemia / therapy*